SuzanneKGazdaMD

PubMed

• 13 citations
  A real-time medical cartography of epidemic disease (Nodding syndrome) using village-based lay mHealth reporters.
  Raquel Valdes Angues, Valerie S. Palmer, Caesar Okot, Robert A. Okot, Concy Atonywalo, Suzanne Gazda, David Lagoro Kitara, Moka Lantum, Peter S. Spencer, Austen Suits> ;Plos Neglected Tropical Diseases. 2018 Jun 15
• 1 citations
  Could Nodding Syndrome (NS) in Northern Uganda be an environmentally induced alteration of ancestral microbiota
  Denis Anywar Arony, Suzanne Gazda, David Lagoro Kitara> ;The Pan African Medical Journal. 2018 Oct 30
• 2 citations
  Could nodding syndrome in Northern Uganda be a form of autism spectrum disorder? an observational study design.
  Denis Anywar Arony, Suzanne Gazda, David Lagoro Kitara> ;The Pan African Medical Journal. 2018 Jan 1
• 6 citations
  Treatment and rehabilitation outcomes of children affected with nodding syndrome in Northern Uganda: a descriptive case series.
  Suzanne Gazda, David Lagoro Kitara> ;The Pan African Medical Journal. 2018 Jan 1
• Nodding syndrome: 2015 International Conference Report and Gulu Accord.
  Spencer, P. S.,Kitara, D. L.,Gazda, S. K.,Winkler, A. S.> ;eNeurologicalSci. 2015 Nov 07
• 186 citations
  Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
  Alasdair Coles, Edward Fox, A. Vladic, Suzanne Gazda, Vesna V. Brinar, Krzysztof Selmaj, A. Skoromets, I. Stolyarov, Adam J. Bass, H. C. Sullivan, David Margolin, Step...> ;Neurology. 2012 Apr 3
• 37 citations
  A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis
  Edward Fox, H. C. Sullivan, Suzanne Gazda, Lori Mayer, L. O'Donnell, K. Melia, Stephen Lake> ;European Journal of Neurology. 2012 Feb 1
• 102 citations
  Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
  Alasdair Coles, Edward Fox, Anton Vladic, Suzanne Gazda, Vesna V. Brinar, Krzysztof Selmaj, Ann D Bass, Daniel Wynn, David Margolin, Stephen Lake, Susan Moran, Jeffrey...> ;The Lancet. Neurology. 2011 Apr 1
• 67 citations
  Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
  David M. Simpson, Suzanne Gazda, Stephen J. Brown, Lynn R. Webster, Shiao-Ping Lu, Jeffrey Tobias, Geertrui F. Vanhove> ;Journal of Pain and Symptom Management. 2010 Jun 1
• 23 citations
  Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
  Douglas L. Arnold, Denise I. Campagnolo, Hillel Panitch, Amit Bar-Or, Jeff F. Dunn, Mark S. Freedman, Suzanne Gazda, Timothy Vollmer> ;Journal of Neurology. 2008 Oct 7
• 71 citations
  Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
  Timothy Vollmer, Hillel Panitch, Amit Bar-Or, Jeff F. Dunn, M. S. Freedman, Suzanne Gazda, Denise I. Campagnolo, F Deutsch, Douglas L. Arnold> ;Multiple Sclerosis. 2008 Jun 1
• 406 citations
  Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
  Amit Bar-Or, Peter A. Calabresi, Douglas L. Arnold, Clyde E. Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panza...> ;Annals of Neurology. 2008 Mar 1
• A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
  Gilliam, F. G., Veloso, F., Bomhof, M. A., Gazda, S. K., Biton, V., Ter Bruggen, J. P., Neto, W., Bailey, C., Pledger, G., Wu, S. C.> ;Neurology. 2003 Jan 28
• Join now to see all